These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21925452)

  • 1. [Are useful prognostic factors in rheumatoid arthritis?].
    Robustillo Villarino M; Rodríguez Moreno J
    Reumatol Clin; 2011; 7(5):339-42. PubMed ID: 21925452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Early recognition of rheumatoid arthritis].
    van der Helm-van Mil AH; Posthumus MD
    Ned Tijdschr Geneeskd; 2011; 155(30-31):A2902. PubMed ID: 22085506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Established rheumatoid arthritis: clinical assessments.
    van Riel PL; Fransen J
    Best Pract Res Clin Rheumatol; 2007 Oct; 21(5):807-25. PubMed ID: 17870029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial management of rheumatoid arthritis.
    Gramling A; O'Dell JR
    Rheum Dis Clin North Am; 2012 May; 38(2):311-25. PubMed ID: 22819086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and management of rheumatoid arthritis.
    Rindfleisch JA; Muller D
    Am Fam Physician; 2005 Sep; 72(6):1037-47. PubMed ID: 16190501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term impact of delay in assessment of patients with early arthritis.
    van der Linden MP; le Cessie S; Raza K; van der Woude D; Knevel R; Huizinga TW; van der Helm-van Mil AH
    Arthritis Rheum; 2010 Dec; 62(12):3537-46. PubMed ID: 20722031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rheumatoid factor by laser nephelometry and Waaler-Rose assay: prognostic value in patients with recent-onset rheumatoid arthritis.
    Nikolaisen C; Rekvig OP; Nossent HC
    Scand J Rheumatol; 2005; 34(4):269-76. PubMed ID: 16195159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression in early rheumatoid arthritis.
    Combe B
    Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):59-69. PubMed ID: 19233046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "5D" Outcome in 52 patients with rheumatoid arthritis surviving 20 years after initial disease modifying antirheumatic drug therapy.
    Capell H; McCarey D; Madhok R; Hampson R
    J Rheumatol; 2002 Oct; 29(10):2099-105. PubMed ID: 12375318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts.
    van der Woude D; Young A; Jayakumar K; Mertens BJ; Toes RE; van der Heijde D; Huizinga TW; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2262-71. PubMed ID: 19644846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained clinical remission in rheumatoid arthritis: prevalence and prognostic factors in an inception cohort of patients treated with conventional DMARDS.
    Jayakumar K; Norton S; Dixey J; James D; Gough A; Williams P; Prouse P; Young A;
    Rheumatology (Oxford); 2012 Jan; 51(1):169-75. PubMed ID: 22096011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging trends in diagnosis and treatment of rheumatoid arthritis.
    Birch JT; Bhattacharya S
    Prim Care; 2010 Dec; 37(4):779-92, vii. PubMed ID: 21050958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease remission the goal of therapy in rheumatoid arthritis.
    Nisar MK; Ostör AJ
    Practitioner; 2010 Dec; 254(1735):17-21, 2. PubMed ID: 21306034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unmet needs in rheumatoid arthritis.
    Bykerk V
    J Rheumatol Suppl; 2009 Jun; 82():42-6. PubMed ID: 19509330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial.
    Svensson B; Boonen A; Albertsson K; van der Heijde D; Keller C; Hafström I
    Arthritis Rheum; 2005 Nov; 52(11):3360-70. PubMed ID: 16255010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
    Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P
    Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 10 year prospective followup of patients with rheumatoid arthritis 1986-96.
    Gordon P; West J; Jones H; Gibson T
    J Rheumatol; 2001 Nov; 28(11):2409-15. PubMed ID: 11708411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment and management of rheumatoid arthritis.
    Haraoui B
    J Rheumatol Suppl; 2009 Jun; 82():2-10. PubMed ID: 19509324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence supporting the benefit of early intervention in rheumatoid arthritis.
    Emery P
    J Rheumatol Suppl; 2002 Nov; 66():3-8. PubMed ID: 12435162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.